Skip to content

Research on the efficacy and syndrome evolution in moderate to severe Atopic Dermatitis patients with Traditional Chinese Medicine treatments based on real world data

Research on the efficacy and syndrome evolution in moderate to severe Atopic Dermatitis patients with Traditional Chinese Medicine treatments based on real world data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078753
Enrollment
Unknown
Registered
2023-12-18
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

Traditional Chinese Medicine Group:Systematically treated with internal and/ or external treatments in Traditional Chinese Medicine therapies including herbal bath, herbal ointment and / or acupunctur
Traditional Chinese Medicine and Western Medicine Group:Receive Traditional Chinese Medicine therapies, and receive any AD western medicine routine basic treatments more than 3 months in the past six

Sponsors

Beijing Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of Williams atopic dermatitis ; 2. Aged 18~85 years old ; 3. Patients who signed the written informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients who are currently participating in or have participated in other clinical studies for the treatment of AD within 1 month prior to this study; 2. The patient is a researcher directly involved in this study; 3. Patients who may not be able to complete the whole process of this study; 4. Patients who are not suitable for treatment with this clinical research method, such as patients who are allergic to therapeutic drugs; those who are of childbearing age and planning to be pregnant; pregnant women or nursing patients; 5.Patients with significant abnormalities in blood system, liver, kidney, heart and other systems; patients with severe primary diseases such as cardiovascular, liver, kidney, brain or hematopoietic system ; patients with mental illness or malignant tumor ; 6. Patients with other skin diseases requiring treatment or indications of infection; 7. Patients who are systematically using corticosteroids, molecular targeted agents or biological agents for other diseases; 8. Patients with acute asthma attack or systematic corticosteroids-maintenance therapy.

Design outcomes

Primary

MeasureTime frame
SCORAD;

Secondary

MeasureTime frame
EASI ;BSA;DLQI;PP-NRS;IGA;POEM;TCM symptom score;IgE;

Countries

China

Contacts

Public ContactDongmei Zhou

Beijing Hospital of Traditional Chinese Medicine

52176857@163.com+86 138 1120 1580

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026